Clinical Trials Directory

Trials / Unknown

UnknownNCT04362384

Topical Vitamin E Ovules for the Treatment of Hemorrhoids

Topical Endorectal Vietamin E Ovules for the Treatment of Grade 2 and 3 Hemorrhoids

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Hospital General Universitario Elche · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with hemorrohoids grade II and III were included. Patients were randomized into 2 groups: * Experimental group: Patients will receive a treatment with vitamin E ovules, which must be placed inside the annus * Control group: Patients will receive a treatment with corticoid ointment, with endoanal application Bleeding, pain and stinging will be evaluated 14 days after beginning the treatment.

Detailed description

Patients with hemorrohoids grade II and III were included. Patients were randomized into 2 groups: * Experimental group: Patients will receive a treatment with vitamin E ovules, which must be placed inside the annus. 1 ovule must be inserted daily during 14 days. * Control group: Patients will receive a treatment with prednisolone ointment, with endoanal application 3 times per day during 14 days. Bleeding, pain and stinging will be evaluated 14 days after beginning the treatment. Quantification of pain will be performed following a visual analogic scale ranging from 0 (absence of symptoms) to 100 (unbearable symptoms).

Conditions

Interventions

TypeNameDescription
DRUGVitamin E ovulesEndoanal vitamin E ovules will be prescribed
DRUGPrednisolone ointmentEndoanal Prednisolone ointment will be prescribed

Timeline

Start date
2020-05-01
Primary completion
2020-10-30
Completion
2020-10-30
First posted
2020-04-24
Last updated
2020-04-24

Source: ClinicalTrials.gov record NCT04362384. Inclusion in this directory is not an endorsement.